Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

IDEAYA Biosciences makes three appointments to management team

IDEAYA Biosciences (NASDAQ:IDYA) promoted Paul Stone to CFO, Andres Briseno to VP finance, and Mick O’Quigley to VP development operations. Continuing his role as IDEAYA’s principal financial and accounting...

July 9, 2019

Executive Moves

ORIC Pharma names Lori Friedman as CSO

Closely-held ORIC Pharmaceuticals appointed Lori Friedman as CSO, responsible for leading ORIC’s research and preclinical development efforts.

July 9, 2019

Executive Moves

Zenabis’ expansion welcomed by Stellarton residents

Zenabis Global’s (TSX:ZENA) expansion in Stellarton, Nova Scotia, is good news for local residents, as the company is looking to fill several positions at that particular facility this summer.

July 4, 2019

Executive Moves

Alternate Health names Dr. Robert Blaine as president, CMO and director

Alternate Health (CSE:AHG; OTCQB:AHGIF) appointed Dr. Robert Blaine as president, CMO and a director, effective immediately.

July 3, 2019

Executive Moves

Canopy Growth announces senior management changes

Bruce Linton is stepping down as co-CEO and a director of Canopy Growth (TSX:WEED; NYSE: CGC) and Mark Zekulin, co-CEO, has agreed to become sole CEO.

July 3, 2019

Executive Moves

BioSig names Samuel Navarro to board

BioSig Technologies (NASDAQ:BSGM) appointed Samuel Navarro as an independent director.

June 25, 2019

Executive Moves

Arcus Biosciences names Eric Hoefer as chief commercial officer

Arcus Biosciences (NYSE:RCUS) appointed Eric Hoefer as its chief commercial officer to oversee the company’s global commercial strategy and operations.

June 24, 2019

Executive Moves

Raymond James names Andrew Gitkin as co-head of health care investment banking

Raymond James named finance professional, Andrew Gitkin, as managing director and co-head of the firm’s health care investment banking practice, along side managing director, Riley Sweat.

June 7, 2019

Executive Moves

Canopy Growth’s medical division names Dr. Marcel Bonn-Miller as global clinical scientific director

Spectrum Therapeutics, the medical division of Canopy Growth (TSX:WEED; NYSE:CGC) appointed Dr. Marcel Bonn-Miller as global clinical scientific director.

June 5, 2019

Executive Moves

Canopy Growth names Mike Lee as acting CFO

Canopy Growth (TSX:WEED; NYSE:CGC) appointed Mike Lee as acting CFO, effective June 1, and subject to Health Canada security clearance required for all officers and directors of the company.

May 21, 2019

Executive Moves

Zenabis provides operational update; appoints Natascha Kiernan to board

Zenabis Global (TSXV:ZENA) provide an update on its recent cannabis production figures, anticipated future harvests, facility construction and licensing status, and medical program update.

May 21, 2019

Executive Moves

Neptune Wellness names Martin Landry as chief of corporate development and strategy

Neptune Wellness Solutions (NASDAQ:NEPT; TSX:NEPT) appointed Martin Landry to the new position of chief of corporate development and strategy, effective May 27.

May 14, 2019

Executive Moves

MediPharm names Braden Fenske as chief strategy officer, Dr. Paul Tam as director

MediPharm Labs (TSXV:LABS; OTCQB:MEDIF) appointed Braden Fenske as chief strategy officer and Dr. Paul Tam to its board of directors, effective immediately.

May 1, 2019

Executive Moves

Imagin Medical adds world-renowned bladder cancer expert Dr. Ashish Kamat to SAB

Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) named Dr. Ashish Kamat to its scientific advisory board.

April 17, 2019

Executive Moves

Aurinia Pharma names Peter Greenleaf as CEO; George Milne Jr. as chairman

Aurinia Pharmaceuticals (NASDAQ:AUPH; TSX:AUP) appointed Peter Greenleaf as CEO, and George Milne Jr. as chairman of the board.

April 12, 2019

Executive Moves

Wedbush names Laura Chico as SVP of healthcare equity research

Wedbush Securities appointed Laura Chico, SVP of equity research on the healthcare and biotech team.

April 2, 2019

Executive Moves

Celyad promotes Filippo Petti to CEO

Celyad SA (NASDAQ:CYAD) of Belgium named Filippo Petti, currently CFO, to the post of CEO, effective April 1, 2019.

March 29, 2019

Executive Moves

Roth promotes Yasmeen Rahimi to co-head biotech research

Roth Capital Partners promoted Yasmeen Rahimi, managing director and senior research analyst, to the position of co-head of biotechnology research.

March 28, 2019

Executive Moves

BriaCell Therapeutics names two biopharma experts to its board

BriaCell Therapeutics (TSV-V:BCT; OTCQB:BCTXF) appointed Dr. Rebecca Taub and Vaughn Embro-Pantalony as directors, and current board members Dr. Saeid Babaei, Rahoul Sharan, and Martin Schmieg have resigned, effective...

March 18, 2019

Executive Moves

C4 Therapeutics appoints Adam Crystal as CMO

C4 Therapeutics appointed a new CMO, Dr. Adam Crystal, to oversee clinical development of its pipeline of protein degrader-based therapeutics.

March 14, 2019

Executive Moves

BioSig appoints Barry Keenan as VP of engineering

BioSig Technologies (NASDAQ:BSGM) named Barry Keenan as VP of engineering to head up the company’s advanced product development.

March 6, 2019

Executive Moves

Roth names Tony Butler as head of biotech research

Roth Capital Partners appointed Charles “Tony” Butler as a managing director, senior research analyst and head of biotechnology research, and a partner.

February 21, 2019

Subscribe